Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.84 USD | -1.60% | -3.66% | +30.50% |
Business Summary
Number of employees: 83
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Mental Health Innovations
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +34.76% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States and Germany
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +34.76% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Florian Brand
CEO | Chief Executive Officer | 37 | 18-05-31 |
Srinivas Rao
FOU | Founder | 55 | 18-05-31 |
Anne Johnson
DFI | Director of Finance/CFO | - | 20-12-31 |
Kevin Craig
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Arvind Tewari
COO | Chief Operating Officer | 39 | 20-12-31 |
Frank Stegert
CIO | Chief Investment Officer | 41 | - |
Samantha Bender
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Chief Tech/Sci/R&D Officer | 55 | 19-12-31 | |
Chris Lee
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Michael Raven
COO | Chief Operating Officer | - | 21-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sabrina Johnson
BRD | Director/Board Member | 57 | 20-12-31 |
Founder | 46 | 18-05-31 | |
Amir Kalali
BRD | Director/Board Member | 58 | - |
Andrea Smiley
BRD | Director/Board Member | 56 | 20-12-31 |
Jason Camm
BRD | Director/Board Member | 35 | 21-12-31 |
Michael Auerbach
BRD | Director/Board Member | 48 | 21-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 166,026,396 | 149,440,170 ( 90.01 %) | 0 | 90.01 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
INTELGENX TECHNOLOGIES CORP. 21.36% | 37,300,000 | 21.36% | 6,564,800 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany. |
Pharmaceuticals: Major
|
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.50% | 308M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+45.26% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- ATAI Stock
- Company Atai Life Sciences N.V.